A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease (Q55952474)

Europe PubMed Central

PubMed publication ID

1846940

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846940

full work available at URL

8 December 2022

language of work or name

English

0 references

publication date

21 February 1991

0 references

http://content.nejm.org/cgi/content/abstract/324/8/509

online access status

open access

1 reference

Europe PubMed Central

PubMed publication ID

1846940

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846940

http://www.nejm.org/doi/pdf/10.1056/NEJM199102213240801

8 December 2022

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1056/NEJM199102213240801

The New England Journal of Medicine

8 December 2022

published in

0 references

volume

324

0 references

issue

0 references

page(s)

509-516

0 references

cites work

Clinical features and current management of chronic granulomatous disease.

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Leukocyte oxidase: defective activity in chronic granulomatous disease

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Defective superoxide production by granulocytes from patients with chronic granulomatous disease

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

The respiratory burst oxidase

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Defect in Pyridine Nucleotide Dependent Superoxide Production by a Particulate Fraction from the Granulocytes of Patients with Chronic Granulomatous Disease

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Absence of both cytochrome b−245 subunits from neutrophils in X-linked chronic granulomatous disease

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal location

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors.

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Cytosolic components of the respiratory burst oxidase: resolution of four components, two of which are missing in complementing types of chronic granulomatous disease

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Ciba Foundation Symposium

8 December 2022

118

211

Nathan

1986

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1056/NEJM199102213240801

Gamma interferon is able to enhance the oxidative metabolism of human neutrophils

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Administration of recombinant interferon gamma to cancer patients enhances monocyte secretion of hydrogen peroxide

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Interferon-gamma, the activated macrophage, and host defense against microbial challenge

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Interaction of human monocytes, macrophages, and polymorphonuclear leukocytes with zymosan in vitro. Role of type 3 complement receptors and macrophage-derived complement

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Cox's Regression Model for Counting Processes: A Large Sample Study

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

Nonparametric Estimation from Incomplete Observations

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

A Multiple Testing Procedure for Clinical Trials

8 December 2022

1 reference

https://api.crossref.org/works/10.1056/NEJM199102213240801

8 December 2022

Identifiers

DOI